logo
Mother's Tumor Removed Through a Chance Encounter with Mercy Ships

Mother's Tumor Removed Through a Chance Encounter with Mercy Ships

Zawya10-02-2025

A 45-year-old woman has had a debilitating, an orange-sized tumor surgically removed from her jaw for free after she was spotted by team workers from international charity Mercy Ships (www.MercyShips.org) in her village in Madagascar.
Unable to afford surgery, mother-of-four Marie Elisa had lived with the growing tumor for five years. The condition caused severe weight loss, forced her to stop farming, and left her family struggling financially.
What began as a simple toothache at age 40 became relentless pain that drove her to a pharmacy in Berangotra, a village in central Madagascar, where she was given pain relievers.
Marie Elisa recalled: 'The painkillers helped for a time. The swelling started, and it just kept getting bigger until it reached this point.'
As the tumor grew, she could no longer farm, and her family lost their income. This forced her youngest daughter to drop out of school.
"I could no longer work in the fields or sell at the market," she said. "And my daughter had to stop school because I couldn't pay her fees."
Every day, Marie Elisa walked to her local church to pray. 'I'm praying to Jesus to be healthy and able to work again,' she explained.
Desperate for relief, she turned to traditional healers, but the tumor continued to grow. Though a doctor recommended surgery, the cost was far beyond her means.
In January 2024, a patient selection team from Mercy Ships was traveling across Madagascar to find patients for free surgeries aboard the hospital ship Africa Mercy®, docked in Toamasina. During their journey, a cyclone in northern Madagascar disrupted their plans, forcing the team to take an unplanned route.
Driving through a small village they had not intended to visit, they noticed a woman with a visible tumor walking by the market—Marie Elisa.
'We saw Marie Elisa walking through the market and three of us yelled, 'Stop the bus!'' recalled Maddy Hartung, an Australian volunteer nurse with the team.
They stepped off the bus, weaving through the curious crowd, introducing themselves, and sharing photos of patients who had received life-changing surgery on the ship.
'We explained that we'd seen someone we might be able to help,' Maddy said. 'The whole village turned, pointing at Marie Elisa, rushing over to bring her to meet us.'
The team set up a temporary clinic on the village chief's front porch to examine Marie Elisa, explaining the possibility of free surgery. Though initially cautious, she took a leap of faith. 'I was sick and willing to risk it—I had nothing to lose,' she said.
Emboldened by the possibility of free healthcare, Marie Elisa mentioned that her husband, Claude, had an eye issue. After the assessment, the team found him eligible for eye surgery. Both were ultimately scheduled for free surgeries on the Africa Mercy, albeit at separate times.
'She was meant to be on that side of the road; God had a plan for her,' Maddy reflected.
Marie Elisa traveled for three days to Toamasina to the ship. Due to severe weight loss from the tumor, the doctors put her on a nutrition program to regain strength. Weeks later, she was cleared for surgery.
She received care from volunteer crew onboard including UK and US maxillofacial and head and neck surgeons Dr. Leo Cheng and Dr. Gary Parker.
Dr. Erik Andersen, a volunteer anesthetic supervisor from Australia, reflected on her case: 'Without surgery, her condition would have worsened, with the mass pressing on her airway and making it hard to breathe or eat.'
'I thank God the tumor was removed and I'm healthy again. The surgery went well, and now I can eat normally without any issues,' Marie Elisa shared eagerly, ready to return home after her successful operation.
When Marie Elisa returned home safely, her husband Claude was relieved. 'With her so far away, all I could do was pray,' he recalled. 'I kept saying, 'Oh God, please heal my wife and free her from this illness.''
A few weeks later, it was Claude's turn for surgery to remove a cyst from his left eye—a condition that had affected him for five years. This time, Marie Elisa returned to the ship not as a patient, but as his caregiver.
When Claude was discharged, the couple was filled with hope for the future.
For Marie Elisa, the thought of returning to her vegetable and potato fields brought excitement. 'When I'm fully recovered and nothing bothers me, I can go back to my former job,' she said.
Distributed by APO Group on behalf of Mercy Ships.
For more information about Mercy Ships, contact:
Sophie Barnett
Mercy Ships International PR Manager
international.media@mercyships.org
About Mercy Ships:
Mercy Ships operates hospital ships that deliver free surgeries and other healthcare services to those with little access to safe medical care. An international faith-based organization, Mercy Ships has focused entirely on partnering with African nations for the past three decades. Working with in-country partners, Mercy Ships also provides training to local healthcare professionals and supports the construction of in-country medical infrastructure to leave a lasting impact.
Each year, more than 2,500 volunteer professionals from over 60 countries serve on board the world's two largest non-governmental hospital ships, the Africa Mercy ® and the Global Mercy ™. Professionals such as surgeons, dentists, nurses, health trainers, cooks, and engineers dedicate their time and skills to accelerate access to safe surgical and anesthetic care. Mercy Ships was founded in 1978 and has offices in 16 countries as well as an Africa Service Center in Dakar, Senegal. For more information, visit www.MercyShips.org and follow @ MercyShips on social media.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

MediLink Therapeutics Taps Major Banks for Hong Kong Float
MediLink Therapeutics Taps Major Banks for Hong Kong Float

Arabian Post

time4 days ago

  • Arabian Post

MediLink Therapeutics Taps Major Banks for Hong Kong Float

MediLink Therapeutics Ltd. is preparing to launch an initial public offering in Hong Kong, having secured China International Capital Corp., JPMorgan Chase & Co. and Morgan Stanley as its lead advisers, according to people with knowledge of the matter. The move comes as the clinical-stage biotech firm seeks to capitalise on growing investor interest in advanced tumour-targeting therapies and consolidate its platform of antibody‑drug conjugates. Founded in 2020 and headquartered in Suzhou with R&D operations in Shanghai and Boston, MediLink has developed a proprietary ADC technology known as TMALIN®. The platform facilitates precise delivery of cytotoxic agents to tumour cells, with the intention of widening therapeutic windows for solid tumour treatments. Its pipeline includes programs that have advanced to clinical stages in both China and the United States, supported by a Series B financing round of approximately USD 70 million in 2022. MediLink's strategic engagement of three underwriters reflects heightened confidence in anchor investors and broader syndication. China International Capital Corp. brings deep roots in Chinese capital markets and extensive IPO experience in the biotech sector. JPMorgan and Morgan Stanley add global banking heft and access to international investors. ADVERTISEMENT CICC itself is emerging as a top-tier sponsor for Hong Kong listings. It led or co-led 19 IPOs for Chinese corporates last year, raising USD 3.84 billion, positioning it as a dominant force amid market revival. The engagement of internationally renowned banks alongside CICC is likely aimed at boosting MediLink's valuation and widening investor interest both locally and abroad. While IPO details remain confidential, analysts suggest MediLink could seek a valuation in the mid‑to‑high hundreds of millions of dollars. That would reflect both the advanced stage of its pipeline and prevailing market multiples for ADC developers. Comparable biotech flotations in Hong Kong and the U.S. have reflected growing appetite for oncology-focused platforms. Alongside listing ambitions, MediLink continues to advance its clinical and licensing goals. In March it unveiled preclinical data at the American Association for Cancer Research annual meeting; earlier in the year it received FDA clearance for its IND application for YL217, its lead candidate. YL201, another programme, received Breakthrough Therapy Designation in January for treatment of recurrent/metastatic nasopharyngeal carcinoma. The company has also pursued strategic licensing agreements with global pharmaceutical firms to expand development and commercialisation capabilities. A licensing deal under discussion ahead of the IPO is believed aimed at enhancing distribution reach while reinforcing MediLink's balance sheet. The IPO effort is part of a broader resurgence in biotech listings in Hong Kong, where authorities have eased regulations to attract innovation-driven offerings. CICC and other banks have ramped up support for ADC and gene therapy companies, signalling a turning point after a lull in listings. ADVERTISEMENT MediLink's choice of banks aligns with a wider trend: CICC has co-sponsored blockbuster floats including the forthcoming mega‑IPO of CATL, while banks like Goldman Sachs and Morgan Stanley have also participated. In this context, MediLink is positioning itself to tap both deep domestic networks and international capital. Stakeholder sentiment appears optimistic. MediLink's management team, comprised of co‑founders Tony Xue and Jiaqiang Cai alongside C‑suite leaders experienced in drug development and financial strategy, has overseen steady progress in its ADC pipeline and established global partnerships. Jason Li's appointment as CFO in 2023 reportedly strengthened the company's capital market readiness. Market observers highlight challenges ahead. ADC development remains capital-intensive, clinical risks high, and competition fierce among domestic and international peers. Success will hinge on late‑stage data and licensing traction. At the same time, geopolitical tensions and volatility in Hong Kong equity markets may affect investor sentiment. MediLink must also navigate post‑IPO obligations, including regulatory reporting and corporate governance under Hong Kong's Main Board requirements. Mitigating execution risk will be critical, underscoring the role of its chosen bankers in underwriting diligence and market support. Analysts describe the listing as a pivotal moment: it offers the backing to fund Phase II/III efforts while elevating MediLink's corporate profile. For banks, it reinforces Hong Kong's appeal as a biotech capital market when compared with established centres like Nasdaq. With its IPO process underway, MediLink now awaits market timing and regulatory clearances before formally filing a prospectus. The company is expected to continue advancing clinical data, strengthening licensing ties, and preparing investor materials aligned with regulatory requirements.

Woman Saved from Life-Threatening Neck Growth That Started as Sore Throat
Woman Saved from Life-Threatening Neck Growth That Started as Sore Throat

Zawya

time04-06-2025

  • Zawya

Woman Saved from Life-Threatening Neck Growth That Started as Sore Throat

A young woman whose sore throat became a life-threatening growth in her neck, leaving her struggling to breathe, has had it removed for free by surgeon volunteers from international charity Mercy Ships ( Harimalala from Mankara, on the east coast of Madagascar was just 12 when her throat started to feel uncomfortable and began to swell. 'I took medicines, but it kept growing even more. I even went to a traditional healer, but it kept growing,' she said. The large growth eventually became impossible to ignore. Ashamed of her appearance, Harimalala dropped out of school and wrapped a scarf around her neck to hide the mass. The swelling affected her physically, emotionally, and socially. 'I am unable to fetch water or carry heavy things. I can't bend down or run,' she shared before her surgery. Harimalala feared her condition was life-threatening but like approximately 93% of people in sub-Saharan Africa ( she was unable to access safe, affordable, and timely surgical care. Still unable to find any help at 24 years old, she heard about Mercy Ships from a neighbor — a charity that sends floating hospitals crewed by volunteer medical professionals to provide free surgery. She held onto the hope that they would return to Madagascar. When she heard it had, she traveled alone to the port of Toamasina in 2024 where the volunteers from the Africa Mercy® first met Harimalala. The medical team quickly realized her condition was critical and she could not return home until she had surgery. Dr. AJ Collins, who has led Mercy Ships' thyroid surgery program for 17 years, performed the operation. He described her condition as, 'A typical but massive multinodular goiter, which is the most common type of thyroid pathology worldwide.' 'It tends to compress the airway so breathing and talking and exercising become very difficult. It can make it hard to swallow your food. Those problems just become worse until they get to critical point, which I think for her, was close.' Additionally, Harimalala faced bigger challenges. 'I feel ashamed with people and don't dare go to church because people stare at me. People gossip, they talk – they say I have a big thing on my neck,' she said. She also feared the condition would rob her of the chance to build a future. 'I can't imagine what that's like… seeing all the young people around you get on with their lives and do things like getting married and having families or other things,' said Dr. Collins. 'She had a deep feeling that wasn't going to happen for her.' Her airway was so compromised that Mercy Ships staff raised concerns by email with Dr. Collins. Harimalala spent several months at the HOPE (Hospital OutPatient Extension Center, receiving care to reduce the size of the goiter before surgery could take place. After a complex four-hour procedure, Harimalala was finally freed from the 1.35-kilogram mass, which was almost two pounds in weight. After successful surgery, Harimalala reflected on her future. 'I really like necklaces, but I had goiter so I couldn't wear it but now I can,' she said, smiling broadly. 'I feel like I've entered a new life because the previous one, it was uncertain whether I would die or live. 'I can get married and have children now because the growth is gone,' she added. Learn how you can partner with Mercy Ships to provide hope and healing to people like Harimalala. Visit Distributed by APO Group on behalf of Mercy Ships. For more information about Mercy Ships, contact: Sophie Barnett Mercy Ships International PR Manager About Mercy Ships: Mercy Ships operates hospital ships that deliver free surgeries and other healthcare services to those with little access to safe medical care. An international faith-based organization, Mercy Ships has focused entirely on partnering with African nations for the past three decades. Working with in-country partners, Mercy Ships also provides training to local healthcare professionals and supports the construction of in-country medical infrastructure to leave a lasting impact. Each year, more than 2,500 volunteer professionals from over 60 countries serve on board the world's two largest non-governmental hospital ships, the Africa Mercy ® and the Global Mercy ™. Professionals such as surgeons, dentists, nurses, health trainers, cooks, and engineers dedicate their time and skills to accelerate access to safe surgical and anesthetic care. Mercy Ships was founded in 1978 and has offices in 16 countries as well as an Africa Service Center in Dakar, Senegal. For more information, visit and follow @ MercyShips on social media.

Kyrgios withdraws from Wimbledon due to injury setback
Kyrgios withdraws from Wimbledon due to injury setback

Dubai Eye

time03-06-2025

  • Dubai Eye

Kyrgios withdraws from Wimbledon due to injury setback

Nick Kyrgios will miss Wimbledon and the entire grass court season due to a minor setback in his recovery from injury, the Australian said on Tuesday. The 30-year-old has struggled with a litany of foot, knee and wrist injuries since his runner-up finish at Wimbledon in 2022 and has played only four singles matches this year. He recorded his first singles win since 2022 at the Miami Open in March but pulled out of the French Open with a knee issue. "I've hit a small setback in my recovery and unfortunately won't make it back for grass season this year," Kyrgios posted on social media. "I know how much you've all been looking forward to seeing me out there, and I'm genuinely sorry to disappoint. This is just a bump in the road though, and I'm already working hard to get back stronger than ever." Wimbledon, the third Grand Slam of the year, starts on June 30.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store